Publications by authors named "Francesca Palandri"

100Publications

Is there a gender effect in polycythemia vera?

Ann Hematol 2021 Jan 2;100(1):11-25. Epub 2020 Oct 2.

Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy.

View Article and Find Full Text PDF
January 2021

The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis.

Oncoimmunology 2020 06 23;9(1):1782575. Epub 2020 Jun 23.

Department of Experimental, Institute of Hematology "L. E A. "Seràgnoli", Diagnostic and Specialty Medicine, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

View Article and Find Full Text PDF
June 2020

Disease-Specific Derangement of Circulating Endocannabinoids and -Acylethanolamines in Myeloproliferative Neoplasms.

Int J Mol Sci 2020 May 11;21(9). Epub 2020 May 11.

Institute of Hematology "L. e A. Seràgnoli", Department of Experimental, Diagnostic and Specialty Medicine (DIMES), School of Medicine, University of Bologna, 40138 Bologna, Italy.

View Article and Find Full Text PDF
May 2020

Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib.

Front Oncol 2019 7;9:1186. Epub 2019 Nov 7.

Dipartimento di Scienze Mediche, Chirurgiche e Tecnologie Avanzate "G.F. Ingrassia", University of Catania, Catania, Italy.

View Article and Find Full Text PDF
November 2019

The role of allogeneic stem-cell transplant in myelofibrosis in the era of JAK inhibitors: a case-based review.

Bone Marrow Transplant 2020 04 18;55(4):708-716. Epub 2019 Sep 18.

Section of Hematology, Department of Medicine, University of Verona, Verona, Italy.

View Article and Find Full Text PDF
April 2020

Treating early-stage myelofibrosis.

Ann Hematol 2019 Feb 20;98(2):241-253. Epub 2018 Oct 20.

Division of Hematology, Department of Internal Medicine, University Hospital Ospedale di Circolo e Fondazione Macchi, ASST dei Sette Laghi, Varese, Italy.

View Article and Find Full Text PDF
February 2019

Mutations in and genes are associated with specific alterations of the immune system in myelofibrosis.

Oncoimmunology 2017;6(10):e1345402. Epub 2017 Jul 5.

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. e A. Seràgnoli," University of Bologna, Bologna, Italy.

View Article and Find Full Text PDF
July 2017

The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study.

Oncotarget 2017 Jun;8(23):37239-37249

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology 'L. and A. Seràgnoli', University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

View Article and Find Full Text PDF
June 2017

Circulating Calreticulin Is Increased in Myelofibrosis: Correlation with Interleukin-6 Plasma Levels, Bone Marrow Fibrosis, and Splenomegaly.

Mediators Inflamm 2016;2016:5860657. Epub 2016 Sep 8.

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. and A. Seràgnoli", University of Bologna, Bologna, Italy.

View Article and Find Full Text PDF
September 2016

New strategies in myelofibrosis: the evolving paradigm of disease pathogenesis, prognostication and treatment.

Hematol Oncol 2017 Jun 10;35(2):145-150. Epub 2016 Aug 10.

Department of Hematology and Oncology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Via Massarenti 9, 40138, Bologna, Italy.

View Article and Find Full Text PDF
June 2017

Low-dose methotrexate as treatment of myeloproliferative neoplasms: Proof of principle of clinical activity.

Am J Hematol 2016 08 3;91(8):E329-30. Epub 2016 Jun 3.

Division of Hematology, Azienda Ospedaliera "Bianchi Melacrino Morelli, "Reggio Calabria, Italy.

View Article and Find Full Text PDF
August 2016

Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years.

Am J Hematol 2016 Jun;91(4):E267-72

Institute of Hematology "L. E A. Seràgnoli," Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy.

View Article and Find Full Text PDF
June 2016

Safety and efficacy of ruxolitinib in myelofibrosis patients without splenomegaly.

Br J Haematol 2016 07 28;174(1):160-2. Epub 2015 Oct 28.

Department of Haematology and Oncology, Città della Salute e della Scienza Hospital, Turin, Italy.

View Article and Find Full Text PDF
July 2016

Circulating CD4+CD25-Foxp3+ cells are increased in patients with immune thrombocytopenia.

Immunol Lett 2015 Jul 2;166(1):63-4. Epub 2015 May 2.

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Bologna, Italy.

View Article and Find Full Text PDF
July 2015

Ruxolitinib-associated tuberculosis: a case of successful ruxolitinib rechallenge.

Ann Hematol 2015 Mar 30;94(3):519-20. Epub 2014 Aug 30.

Institute of Hematology "L. and A. Seràgnoli," St Orsola-Malpighi Hospital, Department of Specialistic, Diagnostic and Experimental Medicine, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy,

View Article and Find Full Text PDF
March 2015

The choice of second-line therapy in steroid-resistant immune thrombocytopenia: role of platelet kinetics in a single-centre long-term study.

Am J Hematol 2014 Nov 27;89(11):1047-50. Epub 2014 Aug 27.

Institute of Hematology "L. and A. Serágnoli", Department of Experimental, Diagnostic and Specialty Medicine, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article and Find Full Text PDF
November 2014

Platelet fluctuations during thrombopoietin-receptor agonist treatment: correlation with platelet apoptosis.

Ann Hematol 2015 Feb 4;94(2):339-41. Epub 2014 Jul 4.

Institute of Hematology "L. and A. Seràgnoli", St Orsola-Malpighi Hospital, Department of Specialistic, Diagnostic and Experimental Medicine, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy.

View Article and Find Full Text PDF
February 2015

Definition and treatment of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia.

Expert Rev Hematol 2014 Jun 25;7(3):397-406. Epub 2014 Mar 25.

Department of Hematology and Oncology "L. and A. Seràgnoli", Bologna, Italy.

View Article and Find Full Text PDF
June 2014

Treatment recommendations for chronic myeloid leukemia.

Mediterr J Hematol Infect Dis 2014 Jan 2;6(1):e2014005. Epub 2014 Jan 2.

Institute of Hematology "L. and A. Seràgnoli", Department of Specialty, Diagnostic and Experimental Medicine, University of Bologna, S.Orsola-Malpighi University Hospital, Bologna, Italy.

View Article and Find Full Text PDF
January 2014

Romiplostim as early treatment of immune thrombocytopenia with severe immunodeficiency.

Hematol Rep 2012 May 26;4(2):e10. Epub 2012 Jun 26.

Department of Hematology and Oncology L. e A. Seràgnoli, St. Orsola-Malpighi Hospital, University of Bologna;

View Article and Find Full Text PDF
May 2012

Imatinib in chronic myeloid leukemia elderly patients.

Aging (Albany NY) 2011 Dec;3(12):1125-6

Department of Hematology and Clinical Oncology "Seràgnoli", S.Orsola-Malpighi Hospital, University of Bologna, Italy.

View Article and Find Full Text PDF
December 2011

Physician's guide to the clinical management of adverse events on nilotinib therapy for the treatment of CML.

Cancer Treat Rev 2012 May 12;38(3):241-8. Epub 2011 Aug 12.

Department of Hematology and Oncology, L. and A. Seràgnoli, St. Orsola University Hospital, University of Bologna, 9-40138 Bologna, Italy.

View Article and Find Full Text PDF
May 2012

Second-generation BCR-ABL inhibitors for frontline treatment of chronic myeloid leukemia in chronic phase.

Crit Rev Oncol Hematol 2012 May 11;82(2):159-70. Epub 2011 May 11.

Department of Hematology and Oncology L. and A. Seràgnoli, University of Bologna, Italy.

View Article and Find Full Text PDF
May 2012

Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: a retrospective study.

Ann Hematol 2011 Aug 2;90(8):933-8. Epub 2011 Feb 2.

Department of Hematology and Oncology L. e A. Seràgnoli, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article and Find Full Text PDF
August 2011

The CD47 pathway is deregulated in human immune thrombocytopenia.

Exp Hematol 2011 Apr 4;39(4):486-94. Epub 2011 Jan 4.

Department of Hematology and Oncological Sciences L. & A. Seràgnoli, Institute of Hematology, University of Bologna, Bologna, Italy.

View Article and Find Full Text PDF
April 2011

Dasatinib and nilotinib in imatinib-resistant Philadelphia-positive chronic myelogenous leukemia: a 'head-to-head comparison'.

Leuk Lymphoma 2010 Apr;51(4):583-91

Department of Hematology and Oncology L. e A. Seràgnoli, S. Orsola-Malpighi University Hospital, 9-40138 Bologna, Italy.

View Article and Find Full Text PDF
April 2010

Response definitions and European Leukemianet Management recommendations.

Best Pract Res Clin Haematol 2009 Sep;22(3):331-41

Department of Hematology-Oncology L. and A. Seràgnoli, S.Orsola-Malpighi University Hospital, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy.

View Article and Find Full Text PDF
September 2009

Pancreatic enzyme elevation in chronic myeloid leukemia patients treated with nilotinib after imatinib failure.

Haematologica 2009 Dec 16;94(12):1758-61. Epub 2009 Jul 16.

Department of Hematology and Medical Oncology L. and A. Seràgnoli, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article and Find Full Text PDF
December 2009